TEE
CKPT

Tibra Equities Europe’s Checkpoint Therapeutics CKPT Stock Holding History

Tibra Equities Europe’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-11,600
Closed -$342K – 73
2021
Q2 		$342K Buy
+11,600
New +$321K 0.11% 77

Other funds holding CKPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAG
Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return

Tibra Equities Europe's CKPT Position: Q3 2021 in Review

Tibra Equities Europe sold out of Checkpoint Therapeutics (CKPT) in Q3 2021, closing a stake of 11,600 shares — an estimated $342K sold.

Tibra Equities Europe first reported a position in CKPT in Q2 2021 and held it in 1 quarter. The position peaked at $342K in Q2 2021. 67 funds tracked by Wall St. Rank hold CKPT as of Q3 2021.

  • Tibra Equities Europe reported no remaining Checkpoint Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Tibra Equities Europe sold 11,600 Checkpoint Therapeutics shares in Q3 2021, an estimated $342K.
  • Tibra Equities Europe first reported a position in Checkpoint Therapeutics in Q2 2021 and held it in 1 quarter.
  • Tibra Equities Europe's Checkpoint Therapeutics position peaked at $342K in Q2 2021.
  • 67 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q3 2021.

Based on Tibra Equities Europe's 13F filing for Q3 2021, filed 15 Nov 2021.